In addition, high expression of METTL1 is often associated with poor prognosis in tumor patients, and METTL1 depletion affects m7G tRNA modification and changes the cell cycle, which is negatively correlated with oncogenicity (Orellana et al., 2021). The gene discussed is METTL1; the disease is neoplasm.